Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01035424 · ClinicalTrials.gov registry record
Genotype-Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis
A clinical trial of Batten Disease and Late Infantile Neuronal Ceroid Lipofuscinosis, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 48
- Enrollment target
- 1
- Study location
NCT01035424 is a study of Batten Disease and Late Infantile Neuronal Ceroid Lipofuscinosis that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 48 participants, below the 2,825-participant average among 11 other Batten Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01035424, a study of Batten Disease and Late Infantile Neuronal Ceroid Lipofuscinosis, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of the study is to assess the genotype - phenotype correlations of the CNS manifestations of late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal, rare, recessive disorder of the CNS in children. This study will be accomplished by comparing the genotype to a neurologic assessment and Weill Cornell LINCL scale, the UBDRS scale, the standardized CHQ quality of life scale, and the Mullen scale; magnetic resonance imaging (MRI); and routine clinical evaluations. This study is designed to run parallel to a separate study which is being done by the Department of Genetic Medicine, which will use gene transfer to treat the central nervous system (CNS) manifestations of late infantile neuronal ceroid lipofuscinosis.
Conditions Studied
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2009-06 |
| Est. Completion | 2016-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01035424
The ClinicalTrials.gov registry entry for NCT01035424 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,825-participant average among 11 other Batten Disease trials with a reported enrollment target (98% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Batten Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01035424 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01035424 about?
NCT01035424 is a clinical study titled "Genotype-Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis". The primary aim of the study is to assess the genotype - phenotype correlations of the CNS manifestations of late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal, rare, recessive disorder of the CNS in children. This study will be accomplished by comparing the genotype to a neurologic asse...
What is the current status of trial NCT01035424?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2009-06. Estimated completion is 2016-01.
What conditions does trial NCT01035424 study?
This clinical trial studies the following conditions: Batten Disease, Late Infantile Neuronal Ceroid Lipofuscinosis.
Who is sponsoring clinical trial NCT01035424?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01035424 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Batten Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Inherited Retinal Degenerative Disease Registry
RECRUITING
-
Clinical and Neuropsychological Investigations in Batten Disease
RECRUITING
-
NYSCF Scientific Discovery Biobank
RECRUITING
-
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
RECRUITING · Phase 1
-
Investigations of Juvenile Neuronal Ceroid Lipofuscinosis
RECRUITING
-
Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.